Biocidal products are used to combat harmful organisms. The SECB issues Statements on biocidal products that contain pathogenic or genetically modified organisms. The SECB’s evaluation focuses on the biosafety of the products, and possible impacts on humans, animals and the environment. Only applications for biocidal products using pathogenic organisms have so far been submitted.
The active ingredient of this biocidal product consists of spores and Bt toxins of the soil bacterium Bacillus thuringiensis aizawai. The product is used to combat honeycomb moths. In its Statement of 15 October 2007 the SECB approved the authorisation of Mellonex.
- SECB Statement on authorisation of Mellonex (in German) (pdf, 270 KB)
The active agent in Solbac also consists of living spores of the soil bacterium Bacillus thuringiensis israelensis (Bti) and is intended to combat fungus gnat larvae. In its Statement of 25 May 2007 the SECB approved the authorisation of this biocidal product.
VectoBac is a biopesticide; its active ingredient is live spores of the soil bacterium Bacillus thuringiensis israelensis (Bti). These are capable of forming Bt toxins, which can be used in a highly specific way against species of mosquito that are prevalent in some areas of Switzerland. In its Statement of 31.07.2005, the SECB recommended the marketing of VectoBac (in German):
To the top
Last edition: 16.08.2018
Swiss Expert Committee for Biosafety (SECB)
Tel.: +41 (0)58 463 03 55
Tel.: +41 (0)58 463 23 12
Fax: +41 (0)58 464 79 78
Executive Office SECB
c/o Federal Office for the Environment